199 related articles for article (PubMed ID: 33238093)
21. Overview of advances in CRISPR/deadCas9 technology and its applications in human diseases.
Kanafi MM; Tavallaei M
Gene; 2022 Jul; 830():146518. PubMed ID: 35447246
[TBL] [Abstract][Full Text] [Related]
22. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
Swarts DC; van der Oost J; Jinek M
Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
[TBL] [Abstract][Full Text] [Related]
23. Production of R,R-2,3-butanediol of ultra-high optical purity from Paenibacillus polymyxa ZJ-9 using homologous recombination.
Zhang L; Cao C; Jiang R; Xu H; Xue F; Huang W; Ni H; Gao J
Bioresour Technol; 2018 Aug; 261():272-278. PubMed ID: 29673996
[TBL] [Abstract][Full Text] [Related]
24. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
Markus BM; Boydston EA; Lourido S
mSphere; 2021 Oct; 6(5):e0047421. PubMed ID: 34643425
[TBL] [Abstract][Full Text] [Related]
25. CRISPR Interference and Activation to Modulate Transcription in Yarrowia lipolytica.
Misa J; Schwartz C
Methods Mol Biol; 2021; 2307():95-109. PubMed ID: 33847984
[TBL] [Abstract][Full Text] [Related]
26. Programmable CRISPR-Cas transcriptional activation in bacteria.
Ho HI; Fang JR; Cheung J; Wang HH
Mol Syst Biol; 2020 Jul; 16(7):e9427. PubMed ID: 32657546
[TBL] [Abstract][Full Text] [Related]
27. Combining CRISPR and CRISPRi Systems for Metabolic Engineering of E. coli and 1,4-BDO Biosynthesis.
Wu MY; Sung LY; Li H; Huang CH; Hu YC
ACS Synth Biol; 2017 Dec; 6(12):2350-2361. PubMed ID: 28854333
[TBL] [Abstract][Full Text] [Related]
28. Switching the activity of Cas12a using guide RNA strand displacement circuits.
Oesinghaus L; Simmel FC
Nat Commun; 2019 May; 10(1):2092. PubMed ID: 31064995
[TBL] [Abstract][Full Text] [Related]
29. CRISPR-mediated transcriptional activation with synthetic guide RNA.
Strezoska Ž; Dickerson SM; Maksimova E; Chou E; Gross MM; Hemphill K; Hardcastle T; Perkett M; Stombaugh J; Miller GW; Anderson EM; Vermeulen A; Smith AVB
J Biotechnol; 2020 Aug; 319():25-35. PubMed ID: 32470463
[TBL] [Abstract][Full Text] [Related]
30. Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria.
Dong C; Fontana J; Patel A; Carothers JM; Zalatan JG
Nat Commun; 2018 Jun; 9(1):2489. PubMed ID: 29950558
[TBL] [Abstract][Full Text] [Related]
31. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
Berkhout B; Gao Z; Herrera-Carrillo E
Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
[TBL] [Abstract][Full Text] [Related]
32. Multi-layer CRISPRa/i circuits for dynamic genetic programs in cell-free and bacterial systems.
Tickman BI; Burbano DA; Chavali VP; Kiattisewee C; Fontana J; Khakimzhan A; Noireaux V; Zalatan JG; Carothers JM
Cell Syst; 2022 Mar; 13(3):215-229.e8. PubMed ID: 34800362
[TBL] [Abstract][Full Text] [Related]
33. Overcoming Leak Sensitivity in CRISPRi Circuits Using Antisense RNA Sequestration and Regulatory Feedback.
Specht DA; Cortes LB; Lambert G
ACS Synth Biol; 2022 Sep; 11(9):2927-2937. PubMed ID: 36017994
[TBL] [Abstract][Full Text] [Related]
34. Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases.
Kim D; Luk K; Wolfe SA; Kim JS
Annu Rev Biochem; 2019 Jun; 88():191-220. PubMed ID: 30883196
[TBL] [Abstract][Full Text] [Related]
35. A CRISPR/Anti-CRISPR Genome Editing Approach Underlines the Synergy of Butanol Dehydrogenases in Clostridium acetobutylicum DSM 792.
Wasels F; Chartier G; Hocq R; Lopes Ferreira N
Appl Environ Microbiol; 2020 Jun; 86(13):. PubMed ID: 32385078
[TBL] [Abstract][Full Text] [Related]
36. CRISPR/dCas9-Mediated Gene Silencing in Two Plant Fungal Pathogens.
Zhang YM; Zheng L; Xie K
mSphere; 2023 Feb; 8(1):e0059422. PubMed ID: 36655998
[TBL] [Abstract][Full Text] [Related]
37. Effects of amino acids on the fermentation of inulin or glucose to produce R,R-2,3-butanediol using Paenibacillus polymyxa ZJ-9.
Gao J; Jiang RF; Cao C; Ni H; Zhang L; Deng LN; Xu H; Jiang RY
Lett Appl Microbiol; 2019 Dec; 69(6):424-430. PubMed ID: 31613992
[TBL] [Abstract][Full Text] [Related]
38. CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi.
Bendixen L; Jensen TI; Bak RO
Mol Ther; 2023 Jul; 31(7):1920-1937. PubMed ID: 36964659
[TBL] [Abstract][Full Text] [Related]
39. CRISPRi-dCas12a: A dCas12a-Mediated CRISPR Interference for Repression of Multiple Genes and Metabolic Engineering in Cyanobacteria.
Choi SY; Woo HM
ACS Synth Biol; 2020 Sep; 9(9):2351-2361. PubMed ID: 32379967
[TBL] [Abstract][Full Text] [Related]
40. Optimization of Vectors and Targeting Strategies Including GoldenBraid and Genome Editing Tools: GoldenBraid Assembly of Multiplex CRISPR /Cas12a Guide RNAs for Gene Editing in Nicotiana benthamiana.
González B; Vazquez-Vilar M; Sánchez-Vicente J; Orzáez D
Methods Mol Biol; 2022; 2480():193-214. PubMed ID: 35616865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
